• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉受累对 Takayasu 动脉炎患者长期预后的影响。

Impact of coronary involvement on long-term outcomes in patients with Takayasu's arteritis.

机构信息

Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.

出版信息

Clin Exp Rheumatol. 2020 Nov-Dec;38(6):1118-1126. Epub 2020 Feb 14.

PMID:32083549
Abstract

OBJECTIVES

To identify the predictors of coronary involvement, and to determine the impact of coronary involvement on long-term outcomes in patients with Takayasu's arteritis (TAK).

METHODS

This retrospective cohort study of TAK patients with coronary evaluation by angiography or computed tomography angiography was conducted in a tertiary center between 1990 and 2018. Risk factors for coronary involvement and predictors of overall survival, cardiovascular event-free survival, and relapse-free survival were investigated.

RESULTS

The median follow-up was 4.3 years (IQR 2.8-7.1). Out of 130 consecutive TAK patients, 71 (54.6%) had coronary involvement. Multivariate analysis revealed that age (OR: 1.537 per 10-year increase, 95% CI: 1.176-2.009, p=0.002) and type V angiographic classification (OR: 3.449, 95% CI: 1.600-7.437, p=0.002) were independent predictors of coronary involvement. Coronary involvement (HR: 8.358, 95% CI: 1.887-37.033, p=0.015), left ventricular systolic dysfunction (HR: 3.889, 95% CI: 1.467-10.311, p=0.006), and aortic regurgitation (HR: 3.373, 95% CI: 1.209-9.408, p=0.020) were independent predictors of overall survival. Furthermore, coronary involvement and baseline active disease were independently associated with increased major cardiovascular events (HR: 10.333, 95% CI: 2.326-45.906, p=0.017; HR: 7.084, 95% CI: 1.677-29.914, p=0.008, respectively) and relapse (HR: 5.186, 95% CI: 2.381-11.295, p<0.001; HR: 5.694, 95% CI: 2.022-16.031, p=0.001, respectively). No immunosuppressive therapy was independently associated with increased cardiovascular events (HR: 2.560, 95% CI: 1.181-5.550, p=0.002).

CONCLUSIONS

Coronary involvement is an important predictor of poor long-term outcomes in patients with TAK. Increasing age and type V angiographic classification can help to identify TAK patients with coronary involvement.

摘要

目的

确定冠状动脉受累的预测因素,并确定冠状动脉受累对大动脉炎(TAK)患者长期结局的影响。

方法

本研究回顾性分析了 1990 年至 2018 年在一家三级中心接受冠状动脉造影或计算机断层血管造影评估的 TAK 患者,探讨了冠状动脉受累的危险因素和总生存、无心血管事件生存和无复发生存的预测因素。

结果

中位随访时间为 4.3 年(IQR 2.8-7.1)。130 例连续 TAK 患者中,71 例(54.6%)有冠状动脉受累。多因素分析显示,年龄(每增加 10 岁,OR:1.537,95%CI:1.176-2.009,p=0.002)和血管造影 V 型分类(OR:3.449,95%CI:1.600-7.437,p=0.002)是冠状动脉受累的独立预测因素。冠状动脉受累(HR:8.358,95%CI:1.887-37.033,p=0.015)、左心室收缩功能障碍(HR:3.889,95%CI:1.467-10.311,p=0.006)和主动脉瓣反流(HR:3.373,95%CI:1.209-9.408,p=0.020)是总生存的独立预测因素。此外,冠状动脉受累和基线活动期疾病与主要心血管事件(HR:10.333,95%CI:2.326-45.906,p=0.017;HR:7.084,95%CI:1.677-29.914,p=0.008)和复发(HR:5.186,95%CI:2.381-11.295,p<0.001;HR:5.694,95%CI:2.022-16.031,p=0.001)的增加有关。未接受免疫抑制治疗与心血管事件增加有关(HR:2.560,95%CI:1.181-5.550,p=0.002)。

结论

冠状动脉受累是 TAK 患者长期预后不良的重要预测因素。年龄增加和血管造影 V 型分类有助于识别有冠状动脉受累的 TAK 患者。

相似文献

1
Impact of coronary involvement on long-term outcomes in patients with Takayasu's arteritis.冠状动脉受累对 Takayasu 动脉炎患者长期预后的影响。
Clin Exp Rheumatol. 2020 Nov-Dec;38(6):1118-1126. Epub 2020 Feb 14.
2
Cardiopulmonary involvement in Takayasu's arteritis.大动脉炎的心肺受累。
Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):46-50. Epub 2017 Jun 12.
3
Paediatric-onset Takayasu's arteritis associates with worse survival than adult-onset Takayasu's arteritis. A matched retrospective cohort study.儿科起病的 Takayasu 动脉炎比成人起病的 Takayasu 动脉炎的生存率更差。一项匹配的回顾性队列研究。
Clin Exp Rheumatol. 2024 Apr;42(4):914-922. doi: 10.55563/clinexprheumatol/gcg7dl. Epub 2023 Aug 16.
4
Clinical course and prognostic factors of childhood Takayasu's arteritis: over 15-year comprehensive analysis of 101 patients.儿童 Takayasu 动脉炎的临床病程和预后因素:101 例患者超过 15 年的综合分析。
Arthritis Res Ther. 2019 Jan 22;21(1):31. doi: 10.1186/s13075-018-1790-x.
5
Monocyte-to-high-density lipoprotein ratio as a predictor for patients with Takayasu arteritis and coronary involvement: a double-center, observational study.单核细胞/高密度脂蛋白比值对 Takayasu 动脉炎合并冠状动脉受累患者的预测价值:一项双中心、观察性研究。
Front Immunol. 2023 Jun 22;14:1120245. doi: 10.3389/fimmu.2023.1120245. eCollection 2023.
6
Coronary artery calcification in Takayasu's arteritis: clinical characteristics and risk factors.Takayasu 动脉炎患者的冠状动脉钙化:临床特征和危险因素。
Clin Exp Rheumatol. 2024 Apr;42(4):843-851. doi: 10.55563/clinexprheumatol/ypq2lj. Epub 2024 Apr 11.
7
Predictors of left ventricular dysfunction in patients with Takayasu's arteritis: a single centre experience.Takayasu 动脉炎患者左心室功能障碍的预测因素:单中心经验。
Clin Exp Rheumatol. 2022 May;40(4):714-719. doi: 10.55563/clinexprheumatol/53koap. Epub 2022 Apr 1.
8
Clinical, angiographic profile and percutaneous endovascular management of Takayasu's arteritis - A single centre experience.大动脉炎的临床、血管造影特征及经皮血管腔内治疗——单中心经验
Int J Cardiol. 2016 Oct 1;220:924-8. doi: 10.1016/j.ijcard.2016.06.194. Epub 2016 Jun 26.
9
Mortality and cardiovascular morbidity among patients diagnosed with Takayasu's arteritis: a Danish nationwide cohort study.Takayasu 动脉炎患者的死亡率和心血管发病率:一项丹麦全国队列研究。
Clin Exp Rheumatol. 2020 Mar-Apr;38 Suppl 124(2):91-94. Epub 2020 Apr 25.
10
Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification.高安动脉炎的临床特征与预后:采用标准化诊断、活动度评估及血管造影分类标准对108例患者的分析
Scand J Rheumatol. 2005 Jul-Aug;34(4):284-92. doi: 10.1080/03009740510026526.

引用本文的文献

1
CD8 cell-derived granzyme B may be a predictor for coronary artery involvement and MACE in Takayasu arteritis patients.CD8细胞衍生的颗粒酶B可能是大动脉炎患者冠状动脉受累和主要不良心血管事件的一个预测指标。
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae095.
2
Multimodality imaging to assess diagnosis and evaluate complications of large vesselarteritis.多模态成像用于评估大动脉炎的诊断及并发症。
J Nucl Cardiol. 2024 Jul;37:101864. doi: 10.1016/j.nuclcard.2024.101864. Epub 2024 Apr 24.
3
Monocyte-to-high-density lipoprotein ratio as a predictor for patients with Takayasu arteritis and coronary involvement: a double-center, observational study.
单核细胞/高密度脂蛋白比值对 Takayasu 动脉炎合并冠状动脉受累患者的预测价值:一项双中心、观察性研究。
Front Immunol. 2023 Jun 22;14:1120245. doi: 10.3389/fimmu.2023.1120245. eCollection 2023.
4
Age, sex and angiographic type-related phenotypic differences in inpatients with Takayasu arteritis: A 13-year retrospective study at a national referral center in China.大动脉炎住院患者的年龄、性别及血管造影类型相关表型差异:中国一家国家级转诊中心的13年回顾性研究
Front Cardiovasc Med. 2023 Mar 16;10:1099144. doi: 10.3389/fcvm.2023.1099144. eCollection 2023.
5
Clinical characteristics and outcomes in patients with Takayasu arteritis coexisting with myocardial ischemia and neurological symptoms: A multicenter, long-term, follow-up study.高安动脉炎合并心肌缺血和神经症状患者的临床特征及预后:一项多中心、长期随访研究
Front Cardiovasc Med. 2022 Aug 3;9:948124. doi: 10.3389/fcvm.2022.948124. eCollection 2022.
6
Novel Therapies in Takayasu Arteritis.大动脉炎的新型治疗方法
Front Med (Lausanne). 2022 Jan 12;8:814075. doi: 10.3389/fmed.2021.814075. eCollection 2021.